The application value of metagenomic next-generation sequencing technology in the diagnosis and treatment of neonatal infectious meningitis - a single center retrospective case-control study
- PMID: 38563313
- DOI: 10.1080/01616412.2024.2337523
The application value of metagenomic next-generation sequencing technology in the diagnosis and treatment of neonatal infectious meningitis - a single center retrospective case-control study
Abstract
Objective: This retrospective study was conducted to investigate the application value of metagenomics next generation sequencing (mNGS) technology in the diagnosis and treatment of neonatal infectious meningitis.
Methods: From 1 January 2020 to 31 December 2022, 73 newborns suspected of infectious meningitis were hospitalized. After screening by inclusion and exclusion criteria, 69 newborns were subsequently included in the study, containing 27 cases with positive mNGS result and 42 cases with negative mNGS result. Furthermore, according to the diagnosis of meningitis, mNGS positive group and mNGS negative group were further divided into infectious meningitis with mNGS (+) group (n = 27) and infectious meningitis with mNGS (-) group (n = 26), respectively.
Results: (1) Compared with cerebrospinal fluid (CSF) culture, mNGS has better diagnostic value [positive predictive value (PPV) = 100.00% (27/27), negative predictive value (NPV) = 38.10% (16/42), agreement rate = 62.32% (43/69), area under the curve (AUC) = 0.750, 95% confidence interval (CI): 0.636-0.864]. (2) There were significant differences in the onset age, age at first CSF test, CSF leukocyte count, CSF glucose, positive rate of CSF culture, blood leukocyte count, procalcitonin (PCT), C-reaction protein (CRP), age at first mNGS test and adjusting anti-infective medication in the comparison between infectious meningitis with mNGS (+) group and infectious meningitis with mNGS (-) group (p < 0.05). (3) mNGS could help improve the cure rate [crude odds ratio (OR) = 3.393, 95%CI: 1.072-10.737; adjusted OR = 15.580, 95%CI: 2.114-114.798].
Conclusion: Compared with classic meningitis detection methods, mNGS has better PPV, NPV, agreement rate, and AUC. mNGS could help improve the cure rate.
Keywords: Metagenomic next-generation sequencing technology; central nervous system infection; diagnosis; neonate; prognosis.
Similar articles
-
The diagnostic value of metagenomic next-generation sequencing for identifying Streptococcus pneumoniae in paediatric bacterial meningitis.BMC Infect Dis. 2019 Jun 4;19(1):495. doi: 10.1186/s12879-019-4132-y. BMC Infect Dis. 2019. PMID: 31164085 Free PMC article.
-
[Value of metagenomic next-generation sequencing in the etiology diagnosis of bacterial meningitis in children].Zhonghua Er Ke Za Zhi. 2022 Aug 2;60(8):769-773. doi: 10.3760/cma.j.cn112140-20220317-00214. Zhonghua Er Ke Za Zhi. 2022. PMID: 35922186 Chinese.
-
The application value of metagenomic next-generation sequencing in community-acquired purulent meningitis after antibiotic intervention.BMC Infect Dis. 2023 Oct 12;23(1):683. doi: 10.1186/s12879-023-08672-4. BMC Infect Dis. 2023. PMID: 37828452 Free PMC article.
-
Diagnostic accuracy of the metagenomic next-generation sequencing (mNGS) for detection of bacterial meningoencephalitis: a systematic review and meta-analysis.Eur J Clin Microbiol Infect Dis. 2022 Jun;41(6):881-891. doi: 10.1007/s10096-022-04445-0. Epub 2022 Apr 26. Eur J Clin Microbiol Infect Dis. 2022. PMID: 35474146
-
Neonatal Ureaplasma parvum meningitis complicated with subdural hematoma: a case report and literature review.BMC Infect Dis. 2021 Mar 17;21(1):268. doi: 10.1186/s12879-021-05968-1. BMC Infect Dis. 2021. PMID: 33731039 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous